CD30 assay will help predict which patients may benefit from treatment in planned Phase III trials. Partners Seattle Genetics and Millennium are tapping Roche’s Ventana Medical Systems business to ...
The companion diagnostic trend continues and Ventana Medical Systems is involved yet again. This morning, Seattle Genetics ($SGEN) and Takeda's Millennium unit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results